Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
23.69
-0.47 (-1.95%)
Apr 29, 2026, 2:28 PM EDT - Market open
Eton Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 25.94 | 14.94 | 21.39 | 16.31 | 14.41 | Upgrade
|
| Cash & Short-Term Investments | 25.94 | 14.94 | 21.39 | 16.31 | 14.41 | Upgrade
|
| Cash Growth | 73.69% | -30.17% | 31.17% | 13.18% | -32.35% | Upgrade
|
| Receivables | 11.76 | 5.36 | 3.41 | 1.85 | 5.47 | Upgrade
|
| Inventory | 15.42 | 15.23 | 0.91 | 0.56 | 0.55 | Upgrade
|
| Prepaid Expenses | 7.46 | 5.49 | 1.13 | 1.29 | 3.18 | Upgrade
|
| Total Current Assets | 60.58 | 41.02 | 26.84 | 20 | 23.6 | Upgrade
|
| Property, Plant & Equipment | 0.64 | 0.21 | 0.15 | 0.26 | 0.22 | Upgrade
|
| Other Intangible Assets | 30.88 | 34.88 | 4.74 | 4.75 | 3.62 | Upgrade
|
| Other Long-Term Assets | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Total Assets | 92.11 | 76.12 | 31.74 | 25.03 | 27.47 | Upgrade
|
| Accounts Payable | 10.98 | 4.17 | 1.85 | 1.77 | 1.77 | Upgrade
|
| Accrued Expenses | 15.94 | 15.7 | 8.96 | 3.66 | 1.37 | Upgrade
|
| Current Portion of Long-Term Debt | 8.79 | - | 5.38 | 1.03 | 1.42 | Upgrade
|
| Current Portion of Leases | 0.07 | 0.08 | 0.05 | - | - | Upgrade
|
| Current Unearned Revenue | 0.46 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 2.26 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 38.49 | 19.95 | 16.24 | 6.46 | 4.56 | Upgrade
|
| Long-Term Debt | 21.77 | 29.81 | - | 5.38 | 5.26 | Upgrade
|
| Long-Term Leases | 0.46 | 0.11 | 0.02 | 0.11 | 0.02 | Upgrade
|
| Long-Term Unearned Revenue | 1.76 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 3.48 | 1.83 | - | - | - | Upgrade
|
| Total Liabilities | 65.96 | 51.7 | 16.26 | 11.95 | 9.84 | Upgrade
|
| Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 138.62 | 132.29 | 119.52 | 116.19 | 111.72 | Upgrade
|
| Retained Earnings | -112.49 | -107.89 | -104.07 | -103.13 | -94.11 | Upgrade
|
| Total Common Equity | 26.15 | 24.43 | 15.48 | 13.08 | 17.63 | Upgrade
|
| Shareholders' Equity | 26.15 | 24.43 | 15.48 | 13.08 | 17.63 | Upgrade
|
| Total Liabilities & Equity | 92.11 | 76.12 | 31.74 | 25.03 | 27.47 | Upgrade
|
| Total Debt | 31.08 | 29.99 | 5.46 | 6.52 | 6.7 | Upgrade
|
| Net Cash (Debt) | -5.14 | -15.06 | 15.93 | 9.78 | 7.71 | Upgrade
|
| Net Cash Growth | - | - | 62.90% | 26.85% | -45.52% | Upgrade
|
| Net Cash Per Share | -0.19 | -0.58 | 0.62 | 0.39 | 0.31 | Upgrade
|
| Filing Date Shares Outstanding | 27.28 | 26.82 | 25.69 | 25.46 | 24.63 | Upgrade
|
| Total Common Shares Outstanding | 27.05 | 26.71 | 25.69 | 25.35 | 24.63 | Upgrade
|
| Working Capital | 22.09 | 21.07 | 10.6 | 13.54 | 19.05 | Upgrade
|
| Book Value Per Share | 0.97 | 0.91 | 0.60 | 0.52 | 0.72 | Upgrade
|
| Tangible Book Value | -4.72 | -10.45 | 10.74 | 8.32 | 14.01 | Upgrade
|
| Tangible Book Value Per Share | -0.17 | -0.39 | 0.42 | 0.33 | 0.57 | Upgrade
|
| Machinery | 0.52 | 0.38 | 0.35 | 0.34 | 0.4 | Upgrade
|
| Construction In Progress | - | - | - | 0.01 | - | Upgrade
|
| Leasehold Improvements | 0.3 | 0.1 | 0.1 | 0.07 | 0.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.